A major mechanism of aging: telomere shortening
- Telomeres are the protective caps of our DNA
- Telomeres shorten over time
- When telomeres become too short, our cells can't function
- This is a major cause of aging
Therapeutic mRNA to extend telomeres
- Messenger RNA encoding telomerase (TERT mRNA)
- One dose reverses years of telomere shortening in days
- Invented by the founders while at Stanford University
- Works in vivo
Pipeline
We have a robust pipeline targeting the fundamental mechanisms of aging. Our goal is to make rejuvenation treatments as routine as getting a flu shot.
Team
John Ramunas
Founder & CEO, Stanford PhD, Co-inventor, Decade of experience with mRNA for therapeutic applications. Thesis title: Telomere extension to extend human healthspan.
Glenn Markov
Founder & COO, Stanford PhD, Decade of experience in genetics and epigenetics of cellular reprogramming.
Bo Yang
Research Fellow, MD, MSc, PhD, CTBS, Clinical and Preclinical Development at Boehringer Ingelheim and Gilead. Postdoc at Yale University on novel roles of ion transport proteins.
Kyle Brewer
Research Scientist, Postdoc at Stanford University on the proteomics of aging in the liver and brain, PhD in Biophysics at UT Southwestern on neurotransmitter release.
Helen M. Blau
Founder & Advisor, Co-inventor, Professor at Stanford University, discovered that short telomeres underlie the fatal etiology of multiple monogenic diseases.
Apoorva Shankar
Life Science Research Associate, MSc in Biotechnology.
Jordan
Spice
Bioengineering Research Associate, BSc in Bioengineering
Robin E. Holbrook
Director of Finance and Administration, Stanford AB in Cultural Anthropology, 30+ years of F&A experience supporting research excellence at Stanford School of Medicine.
Contact Us
Employment inquiries: jobs@rejuvenationtech.com
Investor inquiries: investors@rejuvenationtech.com
Study participant inquiries: info@rejuvenationtech.com
General inquiries: info@rejuvenationtech.com
Rejuvenation Technologies Team 2021
